Continuous Versus Single-Shot Spinal Anesthesia for Orthopedic Surgery

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

November 15, 2024

Study Completion Date

December 1, 2024

Conditions
Post Operative Pain
Interventions
DRUG

Bupivacaine 0.5% Injectable Solution

The patient's back was prepared for surgery. They were positioned on their side, with the operative side facing upward. The L3-4 spinal interspace was identified, and numbed, and a thin spinal needle was inserted. After confirming Cerebrospinal Fluid (CSF), 12.5 mg of isobaric bupivacaine 0.5% was injected into the spinal canal.

DRUG

Bupivacaine 0.5% Injectable Solution

The L3-4 spinal interspace was identified, numbed, and a thicker needle (Tuohy needle) was inserted. After confirming Cerebrospinal Fluid (CSF), a thin catheter was inserted into the spinal canal and secured. An initial dose of 1 ml isobaric bupivacaine 0.5% was injected, followed by additional doses as needed to maintain the block height.

DRUG

Isoflurane Inhalant Product

General anesthesia was initiated with propofol and rocuronium. Anesthesia was maintained with isoflurane, with additional rocuronium and fentanyl as needed. Breathing was controlled by the ventilator, and muscle relaxation was reversed at the end of surgery.

Trial Locations (1)

13511

Benha University, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT06625606 - Continuous Versus Single-Shot Spinal Anesthesia for Orthopedic Surgery | Biotech Hunter | Biotech Hunter